Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report

Authors :: Nicholas G. Kounis
Luigi Macchia
Eustachio Nettis
Alessandro Mandurino-Mirizzi
Angelo Vacca
Elisabetta Di Leo
Caterina Foti
Gianfranco Calogiuri
Source :: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 19:335-339
Publication Year :: 2020
Publisher :: Bentham Science Publishers Ltd., 2020.
Abstract: The anti-IgE Omalizumab may be helpful to treat clopidogrel hypersensitivity without stopping thienopyridine administration in patients requirining continuous antiplatellet therapy after coronary stent placement.

Full Text Access

Tools